Stock Rating Downgrade
Reflecting eroding fundamentals and low Appreciation Potential, the Value Trend Rating for Harrow Health Inc (NASDAQ: HROW) fell significantly of late. HROW’s current Value Trend Rating is F and the prior Rating was C. Details supporting this lower rating are included in our next report.
Recent Price Action
Harrow Health Inc (NASDAQ: HROW) stock closed at $9.31 on 12/1/23 after a modest gain of 0.9%. However, unusually low trading volume at 58% of normal accompanied the advance. The stock has risen 1.3% during the last week but has been extremely weak relative to the market over the last nine months.
Current PriceTarget Research Rating
With future capital returns forecasted to be above the cost of capital, HROW is expected to continue to be a major Value Builder.
Harrow Health has a current Value Trend Rating of F (Lowest Rating). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing consistent signals. Harrow Health has a poor Appreciation Score of 23 and a very low Power Rating of 2, triggering the Lowest Value Trend Rating.
Be the first to comment